Yiwei Wang - Publications

Affiliations: 
2015- Biomedical Engineering Tsinghua National University, Beijing, Beijing Shi, China 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Zeng H, Liu Z, Wang Z, Zhou Q, Qi Y, Chen Y, Chen L, Zhang P, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, et al. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses. International Journal of Cancer. PMID 31584197 DOI: 10.1002/ijc.32715  0.48
2018 Wang Y, Liu Z, Shen J. MicroRNA-421-targeted PDCD4 regulates breast cancer cell proliferation. International Journal of Molecular Medicine. PMID 30365117 DOI: 10.3892/ijmm.2018.3932  0.48
2018 Fu Q, Xu L, Wang Y, Jiang Q, Liu Z, Zhang J, Zhou Q, Zeng H, Tong S, Wang T, Qi Y, Hu B, Fu H, Xie H, Zhou L, et al. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion. European Urology. PMID 30293904 DOI: 10.1016/j.eururo.2018.09.030  0.48
2018 Jiang Q, Fu Q, Chang Y, Liu Z, Zhang J, Xu L, Zhu Y, Wang Y, Zhang W, Xu J. CD19 tumor-infiltrating B-cells prime CD4 T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer. Cancer Immunology, Immunotherapy : Cii. PMID 30259082 DOI: 10.1007/s00262-018-2250-9  0.48
2018 Cai D, Yue Y, Su X, Liu M, Wang Y, You L, Xie F, Deng F, Chen F, Luo M, Yuan K. Distinct Anatomical Connectivity Patterns Differentiate Subdivisions of the Nonlemniscal Auditory Thalamus in Mice. Cerebral Cortex (New York, N.Y. : 1991). PMID 29800098 DOI: 10.1093/cercor/bhy115  0.68
2018 Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Xie H, Fu Q, Dai B, Ye D, Xu J. Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle Invasive Bladder Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29514839 DOI: 10.1158/1078-0432.CCR-17-2687  0.48
2017 Zhu Y, Liu Z, Wang Y, Fu H, Wang Z, Xie H, Zhang J, Li G, Dai B, Ye D, Xu J. High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients. Oncoimmunology. 6: e1359450. PMID 29147624 DOI: 10.1080/2162402X.2017.1359450  0.48
2017 Xie F, You L, Cai D, Liu M, Yue Y, Wang Y, Yuan K. Fast Inhibitory Decay Facilitates Adult-like Temporal Processing in Layer 5 of Developing Primary Auditory Cortex. Cerebral Cortex (New York, N.Y. : 1991). 1-17. PMID 29121216 DOI: 10.1093/cercor/bhx284  0.68
2017 Zhang J, Zhu Y, Wang Y, Fu Q, Xie H, Liu Z, Fu H, Cao Y, Xu J, Dai B. Prognostic and Predictive Value of O(6)-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer. Annals of Surgical Oncology. PMID 29116491 DOI: 10.1245/s10434-017-6145-3  0.48
2017 Liu Z, Zhu Y, Wang Y, Fu Q, Fu H, Wang Z, Zhang J, Li G, Xu J, Dai B. Prognostic value of granulocyte colony-stimulating factor in patients with non-metastatic clear cell renal cell carcinoma. Oncotarget. 8: 69961-69971. PMID 29050255 DOI: 10.18632/oncotarget.19540  0.48
2017 Liu Y, Liu Z, Fu Q, Wang Z, Fu H, Liu W, Wang Y, Xu J. Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma. Urologic Oncology. PMID 28347658 DOI: 10.1016/j.urolonc.2017.02.008  0.48
2017 Cai D, Han R, Liu M, Xie F, You L, Zheng Y, Zhao L, Yao J, Wang Y, Yue Y, Schreiner CE, Yuan K. A Critical Role of Inhibition in Temporal Processing Maturation in the Primary Auditory Cortex. Cerebral Cortex (New York, N.Y. : 1991). 1-15. PMID 28334383 DOI: 10.1093/cercor/bhx057  0.68
2016 Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Wang Z, Xie H, Dai B, Xu J, Ye D. Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma. Annals of Surgical Oncology. PMID 27896514 DOI: 10.1245/s10434-016-5702-5  0.48
2016 Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Wang Z, Xie H, Dai B, Xu J, Ye D. High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients. Oncotarget. PMID 27806328 DOI: 10.18632/oncotarget.12961  0.48
Show low-probability matches.